Results 131 to 140 of about 13,784 (200)

Peptide-based strategies for overcoming taxol-resistance in cancer therapy - a narrative review. [PDF]

Pharmacol Rep
Długosz-Pokorska A, Gach-Janczak K.
europepmc   +1 more source

Targeted regulationof STAT3 by miR-29a in mediating Taxol resistance of nasopharyngeal carcinoma cell line CNE-1. [PDF]

Cancer Biomark, 2018
Gao J, Shao Z, Yan M, Fu T, Zhang L, Yan Y.   +5 more
europepmc   +1 more source

Physapubescin B inhibits tumorgenesis and circumvents taxol resistance of ovarian cancer cells through STAT3 signaling. [PDF]

Oncotarget, 2017
Zhao X, Huang L, Xu W, Chen X, Shen Y, Zeng W, Chen X.   +6 more
europepmc   +1 more source

Effects of taxol resistance gene 1 expression on the chemosensitivity of SGC-7901 cells to oxaliplatin. [PDF]

Exp Ther Med, 2016
Liu L, Bai Z, Ma X, Wang T, Yang Y, Zhang Z.   +5 more
europepmc   +1 more source

Overexpression of caveolin-1 reduces Taxol resistance in human osteosarcoma cells by attenuating PI3K-Akt-JNK dependent autophagy. [PDF]

Exp Ther Med, 2016
Guan J, Yuan Z, He J, Wu Z, Liu B, Lin X, Mo L, Mo H.   +7 more
europepmc   +1 more source

Recent paclitaxel formulation strategies: expanding the therapeutic index by addressing biopharmaceutical and toxicity limitations. [PDF]

Arch Pharm Res
Lee J, Choi MK, Song IS.
europepmc   +1 more source

NTRK2 promotes malignant progression and paclitaxel resistance of lung adenocarcinoma through targeting MYC/ABCF1 axis. [PDF]

Transl Oncol
Cui R, Wang Y, Yao Y, Ren X, Zhang Y, Li D, Hou P, Ji M, Qu Y.   +8 more
europepmc   +1 more source

Alterations in ovarian cancer cell adhesion drive taxol resistance by increasing microtubule dynamics in a FAK-dependent manner. [PDF]

Sci Rep, 2015
McGrail DJ, Khambhati NN, Qi MX, Patel KS, Ravikumar N, Brandenburg CP, Dawson MR.   +6 more
europepmc   +1 more source

Oscillatory dynamics in paclitaxel-proteinoid networks. [PDF]

Discov Mol
Mougkogiannis P, Adamatzky A.
europepmc   +1 more source